医学
神经炎症
2019-20冠状病毒爆发
2019年冠状病毒病(COVID-19)
神经科学
病毒学
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
倍他科诺病毒
免疫学
心理学
病理
炎症
疾病
传染病(医学专业)
爆发
作者
Woo‐Jung Song,Christopher Hui,James H. Hull,Surinder S. Birring,Lorcan McGarvey,Stuart B. Mazzone,Kian Fan Chung
标识
DOI:10.1016/s2213-2600(21)00125-9
摘要
Cough is one of the most common presenting symptoms of COVID-19, along with fever and loss of taste and smell. Cough can persist for weeks or months after SARS-CoV-2 infection, often accompanied by chronic fatigue, cognitive impairment, dyspnoea, or pain-a collection of long-term effects referred to as the post-COVID syndrome or long COVID. We hypothesise that the pathways of neurotropism, neuroinflammation, and neuroimmunomodulation through the vagal sensory nerves, which are implicated in SARS-CoV-2 infection, lead to a cough hypersensitivity state. The post-COVID syndrome might also result from neuroinflammatory events in the brain. We highlight gaps in understanding of the mechanisms of acute and chronic COVID-19-associated cough and post-COVID syndrome, consider potential ways to reduce the effect of COVID-19 by controlling cough, and suggest future directions for research and clinical practice. Although neuromodulators such as gabapentin or opioids might be considered for acute and chronic COVID-19 cough, we discuss the possible mechanisms of COVID-19-associated cough and the promise of new anti-inflammatories or neuromodulators that might successfully target both the cough of COVID-19 and the post-COVID syndrome.
科研通智能强力驱动
Strongly Powered by AbleSci AI